TADA3 and breast carcinoma: While previous analyses of ADA3 knockout MEFs have implicated this protein in cell cycle progression [4] and we have reported that ADA3 overexpression and cytoplasmic localization in breast cancer patient specimens specifies poor outcomes [17], the roles of nuclear ADA3 in epithelial cells and the importance of its overexpression in ER+ breast cancer were not examined.